Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.002 Å; R factor = 0.034; wR factor = 0.091; data-to-parameter ratio = 14.8.
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Cg1 and Cg2 are the centroids of the N1,N2,C4-C6 and C19-C24 rings, respectively. 
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Comment
Our previous work evaluating the biological potential of pyrazole derivatives (Abdel-Wahab et al., 2009; Abdel-Aziz et al., 2009; Abdel-Aziz et al., 2010) lead to the characterization of the title compound, (I).
The molecular structure of (I), Fig. 1 , features a tetra-substituted pyrazole ring. The ester group is twisted out of the plane through the five-membered ring (r.m.s. deviation = 0.007 Å) as seen in the value of the O3-C3-C4-N1 torsion angle of -29.04 (11) °. The ring-connected benzene rings, (C13-C18) and (19-C24), form dihedral angles of 72.01 (7) and 48.10 (7) °, respectively, with the pyrazole ring also indicating significant twists; the dihedral angle between the two ring-bound benzene rings is 71.93 (7) °. With respect to the least-squares plane through the pyrazole ring, the sulfonyl-O atoms lie to one side, and the benzene ring to the other; the dihedral angle between the pyrazole and sulfonyl-benzene rings is 70.63 (7)°, indicating an almost orthogonal relationship.
The crystal structure features supramolecular arrays in the ac plane sustained by C-H···O and C-H···π interactions
[involving the pyrazole ring as the acceptor], Fig. 2 and Table 1 . Layers are connected along the b direction by C-H···.π interactions involving methyl-H and the N-bound benzene ring, Fig. 3 and Table 1 . ) showing the atom-labelling scheme and displacement ellipsoids at the 50% probability level. Symmetry codes: (i) x+1, y, z; (ii) −x+2, −y+1, −z; (iii) −x+1, −y+1, −z; (iv) −x+1, −y+1, −z+1; (v) −x+2, −y, −z+1.
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